Case Report
BibTex RIS Cite

Hypersensitive reactions to platelet transfusion: A case report of urticarial hives and pre-septal cellulitis in the context of a patient with Pre-B acute lymphoblastic leukaemia patient

Year 2024, Volume: 54 Issue: 3, 505 - 511, 30.12.2024
https://doi.org/10.26650/IstanbulJPharm.2024.1487556

Abstract

Background and Aims: Adverse transfusion reactions (ADR), such as fever, chills, and urticarial rashes, are significant in clinical practice, particularly in patients with complex histories. Urticarial reactions, characterised by red, itchy welts, are hypersensitivity reactions, whereas cellulitis, a bacterial infection, differs in aetiology and treatment. This study contributes to a better understanding of hypersensitivity in platelet transfusion and improves clinical management strategies for similar cases in the future. In a contemporary case, a 13-year-old man with pre-B ALL receiving chemotherapy developed widespread urticarial rashes, eye redness, and swelling after receiving four units of random donor platelets. Symptoms were successfully managed with symptomatic treatment after consultations with an ophthalmologist and dermatologist.
Materials and Methods: The methodology involves a systematic approach using the Naranjo ADR Probability Scale, Hartwig Severity Scale, and Shumock and Thornton Preventability Scale. These scales comprehensively evaluate different aspects of the case, including the likelihood, severity, and preventability of adverse drug reactions.
Results: Platelet transfusion causes urticarial hives and pre-septal cellulitis. The Naranjo ADR Causality Assessment scored it as 8 (’probable’). The Hartwig Severity Scale classified it as Level 3 (’Moderate’), and the Shumock and Thornton Scale deemed it ’Probably Preventable’, emphasising the need for preventive measures.
Conclusion: This case underscores the complexities of managing transfusion responses in pre-B ALL patients, emphasising the need for close monitoring, timely intervention, and the use of structured adverse drug reaction (ADR) evaluation tools to effectively minimise the risks associated with blood transfusions.

Ethical Statement

The case report was approved by the institutional ethics committee- Ethics Committee of KLE College of Pharmacy, Belagavi (Ref No; KLE/COP/EC/135/2022-23) and certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written consent was obtained from the legal guardian or parent for participation.

References

  • Askari, S., Nollet, K., Debol, S. M., Brunstein, C. G., & Eastlund, T. (2002). Transfusion-related acute lung injury during plasma ex-change: Suspecting the unsuspected. Journal of Clinical Aphere-sis, 17(2), 93-96. https://doi.org/10.1002/jca.10013 google scholar
  • Behnke, O. (1970). Morphology of blood platelet membrane systems. Series Haematological, 3(4), 3-16 google scholar
  • Blieden, C. R., Campuzano-Zuluaga, G., Moul, A., Chapman, J. R., Cioffi-Lavina, M., Ikpatt, O. F., Byrne, G. E., Jr, & Vega, F. (2014). Anaphylactic reaction to platelet transfusion as the initial symptom of undiagnosed systemic mastocytosis: a case report and review of the literature. Journal of Medical Case Reports, 8, 389. https://doi.org/10.1186/1752-1947-8-389 google scholar
  • Choi, Y., Byun, J. M., Kim, I., Park, J. H., Kim, K. H., Kim, J.S., ... Park, H. (2021). Successful management of severe al-lergic reactions to platelet transfusion with omalizumab: A case report. Medicine, 100(44), e27724. https://doi.org/10.1097/MD. 0000000000027724 google scholar
  • Eche, I. J., Nahas, M., Dunn, E., Eche, I. M., & O’Brien, K. L. (2019). Transfusion Reactions: A Case Study of an Ocular Adverse Event During Autologous Transplantation. Clinical Journal of Oncol-ogy Nursing, 23(5), 509-513. https://doi.org/10.1188/19.CJON. 509-513 google scholar
  • Freireich, E. J. (2011). Origins of platelet transfusion therapy. Transfu-sion Medicine Reviews, 25(3), 252-256. https://doi.org/10.1016/ j.tmrv.2011.01.003 google scholar
  • Jacquot, C., & Delaney, M. (2018). Efforts to Eliminate Infectious Agents in Blood Products. Journal of Intensive Care Medicine, 33(10), 543-550. https://doi.org/10.1177/0885066618756589 google scholar
  • Kaushansky, K. (2005). The molecular mechanisms that control thrombopoiesis. The Journal of Clinical Investigation, 115(12), 3339-3347. https://doi.org/10.1172/JCI26674 google scholar
  • Ling, X., Shi, X., & Chen, L. (2017). Severe erythema multiforme-type drug eruption controlled by tumor necrosis factor-a antagonist: A case study. Experimental and Therapeutic Medicine, 14, 57275732. https://doi.org/10.3892/etm.2017.5336 google scholar
  • Margo C. E. (1999). The adverse periocular reaction after blood trans-fusion. American Journal of Ophthalmology, 127(4), 466-467. https://doi.org/10.1016/s0002-9394(98)00384-5 google scholar
  • Nevala-Plagemann, C., Powers, P., Mir-Kasimov, M., & Rose, R. (2019). A Fatal Case of Septic Shock Secondary to Acinetobacter Bacteraemia Acquired from a Platelet Transfusion. Case Reports in Medicine, 3136493. https://doi.org/10.1155/2019/3136493 google scholar
  • Ramanathan, R. K., Triulzi, D. J., & Logan, T. F. (1997). Transfusion-related acute lung injury following random donor platelet trans-fusion: a report of two cases. Vox sanguinis, 73(1), 43-45. https://doi.org/10.1046/j.1423-0410.1997.7310043.x google scholar
  • Siddon, A. J., Kenney, B. C., Hendrickson, J. E., and Tormey, C. A. (2018). Delayed haemolytic and serologic transfusion reac-tions: pathophysiology, treatment and prevention. Current Opinion in Haematology, 25(6), 459-467. https://doi.org/10.1097/ MOH.0000000000000462 google scholar
  • Solves Alcaina P., (2020). Platelet Transfusion: Update on Challenges and Outcomes. Journal of Blood Medicine, 11, 19-26. https://doi. org/10.2147/JBM.S234374 google scholar
  • Suddock JT, Crookston KP. Transfusion Reactions. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): Stat-Pearls Publishing; 2024. Available online: https://www.ncbi.nlm. nih.gov/books/NBK482202/ google scholar
  • Tariket, S., Sut, C., Hamzeh-Cognasse, H., Laradi, S., Garraud, O., & Cognasse, F. (2018). Platelets and TRALI: From blood component to organism. Transfusion Clinique et Biologique, 25(3), 204-209. https://doi.org/10.1016/j.tracli.2018.03.006 google scholar
  • Zaki, S. A. (2011). Adverse drug reaction and causality assess-ment scales. Lung India, 28(2), 152-153. https://doi.org/10.4103/ 0970-2113.80343 google scholar
Year 2024, Volume: 54 Issue: 3, 505 - 511, 30.12.2024
https://doi.org/10.26650/IstanbulJPharm.2024.1487556

Abstract

References

  • Askari, S., Nollet, K., Debol, S. M., Brunstein, C. G., & Eastlund, T. (2002). Transfusion-related acute lung injury during plasma ex-change: Suspecting the unsuspected. Journal of Clinical Aphere-sis, 17(2), 93-96. https://doi.org/10.1002/jca.10013 google scholar
  • Behnke, O. (1970). Morphology of blood platelet membrane systems. Series Haematological, 3(4), 3-16 google scholar
  • Blieden, C. R., Campuzano-Zuluaga, G., Moul, A., Chapman, J. R., Cioffi-Lavina, M., Ikpatt, O. F., Byrne, G. E., Jr, & Vega, F. (2014). Anaphylactic reaction to platelet transfusion as the initial symptom of undiagnosed systemic mastocytosis: a case report and review of the literature. Journal of Medical Case Reports, 8, 389. https://doi.org/10.1186/1752-1947-8-389 google scholar
  • Choi, Y., Byun, J. M., Kim, I., Park, J. H., Kim, K. H., Kim, J.S., ... Park, H. (2021). Successful management of severe al-lergic reactions to platelet transfusion with omalizumab: A case report. Medicine, 100(44), e27724. https://doi.org/10.1097/MD. 0000000000027724 google scholar
  • Eche, I. J., Nahas, M., Dunn, E., Eche, I. M., & O’Brien, K. L. (2019). Transfusion Reactions: A Case Study of an Ocular Adverse Event During Autologous Transplantation. Clinical Journal of Oncol-ogy Nursing, 23(5), 509-513. https://doi.org/10.1188/19.CJON. 509-513 google scholar
  • Freireich, E. J. (2011). Origins of platelet transfusion therapy. Transfu-sion Medicine Reviews, 25(3), 252-256. https://doi.org/10.1016/ j.tmrv.2011.01.003 google scholar
  • Jacquot, C., & Delaney, M. (2018). Efforts to Eliminate Infectious Agents in Blood Products. Journal of Intensive Care Medicine, 33(10), 543-550. https://doi.org/10.1177/0885066618756589 google scholar
  • Kaushansky, K. (2005). The molecular mechanisms that control thrombopoiesis. The Journal of Clinical Investigation, 115(12), 3339-3347. https://doi.org/10.1172/JCI26674 google scholar
  • Ling, X., Shi, X., & Chen, L. (2017). Severe erythema multiforme-type drug eruption controlled by tumor necrosis factor-a antagonist: A case study. Experimental and Therapeutic Medicine, 14, 57275732. https://doi.org/10.3892/etm.2017.5336 google scholar
  • Margo C. E. (1999). The adverse periocular reaction after blood trans-fusion. American Journal of Ophthalmology, 127(4), 466-467. https://doi.org/10.1016/s0002-9394(98)00384-5 google scholar
  • Nevala-Plagemann, C., Powers, P., Mir-Kasimov, M., & Rose, R. (2019). A Fatal Case of Septic Shock Secondary to Acinetobacter Bacteraemia Acquired from a Platelet Transfusion. Case Reports in Medicine, 3136493. https://doi.org/10.1155/2019/3136493 google scholar
  • Ramanathan, R. K., Triulzi, D. J., & Logan, T. F. (1997). Transfusion-related acute lung injury following random donor platelet trans-fusion: a report of two cases. Vox sanguinis, 73(1), 43-45. https://doi.org/10.1046/j.1423-0410.1997.7310043.x google scholar
  • Siddon, A. J., Kenney, B. C., Hendrickson, J. E., and Tormey, C. A. (2018). Delayed haemolytic and serologic transfusion reac-tions: pathophysiology, treatment and prevention. Current Opinion in Haematology, 25(6), 459-467. https://doi.org/10.1097/ MOH.0000000000000462 google scholar
  • Solves Alcaina P., (2020). Platelet Transfusion: Update on Challenges and Outcomes. Journal of Blood Medicine, 11, 19-26. https://doi. org/10.2147/JBM.S234374 google scholar
  • Suddock JT, Crookston KP. Transfusion Reactions. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): Stat-Pearls Publishing; 2024. Available online: https://www.ncbi.nlm. nih.gov/books/NBK482202/ google scholar
  • Tariket, S., Sut, C., Hamzeh-Cognasse, H., Laradi, S., Garraud, O., & Cognasse, F. (2018). Platelets and TRALI: From blood component to organism. Transfusion Clinique et Biologique, 25(3), 204-209. https://doi.org/10.1016/j.tracli.2018.03.006 google scholar
  • Zaki, S. A. (2011). Adverse drug reaction and causality assess-ment scales. Lung India, 28(2), 152-153. https://doi.org/10.4103/ 0970-2113.80343 google scholar
There are 17 citations in total.

Details

Primary Language English
Subjects Pharmacology and Pharmaceutical Sciences (Other)
Journal Section Case Report
Authors

Manjula Gudhoor 0000-0002-7173-6408

Aishwarya Loliyekar 0009-0009-5414-1283

Ayaana Jain 0000-0003-1830-8604

Abhilasha Sampagar 0000-0001-8604-4167

Madiwalayya Ganachari 0000-0003-0098-8752

Publication Date December 30, 2024
Submission Date May 22, 2024
Acceptance Date September 10, 2024
Published in Issue Year 2024 Volume: 54 Issue: 3

Cite

APA Gudhoor, M., Loliyekar, A., Jain, A., Sampagar, A., et al. (2024). Hypersensitive reactions to platelet transfusion: A case report of urticarial hives and pre-septal cellulitis in the context of a patient with Pre-B acute lymphoblastic leukaemia patient. İstanbul Journal of Pharmacy, 54(3), 505-511. https://doi.org/10.26650/IstanbulJPharm.2024.1487556
AMA Gudhoor M, Loliyekar A, Jain A, Sampagar A, Ganachari M. Hypersensitive reactions to platelet transfusion: A case report of urticarial hives and pre-septal cellulitis in the context of a patient with Pre-B acute lymphoblastic leukaemia patient. iujp. December 2024;54(3):505-511. doi:10.26650/IstanbulJPharm.2024.1487556
Chicago Gudhoor, Manjula, Aishwarya Loliyekar, Ayaana Jain, Abhilasha Sampagar, and Madiwalayya Ganachari. “Hypersensitive Reactions to Platelet Transfusion: A Case Report of Urticarial Hives and Pre-Septal Cellulitis in the Context of a Patient With Pre-B Acute Lymphoblastic Leukaemia Patient”. İstanbul Journal of Pharmacy 54, no. 3 (December 2024): 505-11. https://doi.org/10.26650/IstanbulJPharm.2024.1487556.
EndNote Gudhoor M, Loliyekar A, Jain A, Sampagar A, Ganachari M (December 1, 2024) Hypersensitive reactions to platelet transfusion: A case report of urticarial hives and pre-septal cellulitis in the context of a patient with Pre-B acute lymphoblastic leukaemia patient. İstanbul Journal of Pharmacy 54 3 505–511.
IEEE M. Gudhoor, A. Loliyekar, A. Jain, A. Sampagar, and M. Ganachari, “Hypersensitive reactions to platelet transfusion: A case report of urticarial hives and pre-septal cellulitis in the context of a patient with Pre-B acute lymphoblastic leukaemia patient”, iujp, vol. 54, no. 3, pp. 505–511, 2024, doi: 10.26650/IstanbulJPharm.2024.1487556.
ISNAD Gudhoor, Manjula et al. “Hypersensitive Reactions to Platelet Transfusion: A Case Report of Urticarial Hives and Pre-Septal Cellulitis in the Context of a Patient With Pre-B Acute Lymphoblastic Leukaemia Patient”. İstanbul Journal of Pharmacy 54/3 (December 2024), 505-511. https://doi.org/10.26650/IstanbulJPharm.2024.1487556.
JAMA Gudhoor M, Loliyekar A, Jain A, Sampagar A, Ganachari M. Hypersensitive reactions to platelet transfusion: A case report of urticarial hives and pre-septal cellulitis in the context of a patient with Pre-B acute lymphoblastic leukaemia patient. iujp. 2024;54:505–511.
MLA Gudhoor, Manjula et al. “Hypersensitive Reactions to Platelet Transfusion: A Case Report of Urticarial Hives and Pre-Septal Cellulitis in the Context of a Patient With Pre-B Acute Lymphoblastic Leukaemia Patient”. İstanbul Journal of Pharmacy, vol. 54, no. 3, 2024, pp. 505-11, doi:10.26650/IstanbulJPharm.2024.1487556.
Vancouver Gudhoor M, Loliyekar A, Jain A, Sampagar A, Ganachari M. Hypersensitive reactions to platelet transfusion: A case report of urticarial hives and pre-septal cellulitis in the context of a patient with Pre-B acute lymphoblastic leukaemia patient. iujp. 2024;54(3):505-11.